🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial is a multicenter, open-label study to evaluate the safety and ef...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-09
Trial ID
NCT01205451
Treatments Being Tested
Botulinum toxin A (GSK1358820) is a sterile, purified type A botulinum neur...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-08-02
Trial ID
NCT03261167
Treatments Being Tested
The primary objective of this study is to demonstrate superiority of single...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-04
Trial ID
NCT01128738
Treatments Being Tested
This is a study to confirm the superior efficacy of a single treatment of G...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-05
Trial ID
NCT00460564
Treatments Being Tested
GSK1358820 is a botulinum neurotoxin A complex that has been approved for t...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-08-10
Trial ID
NCT02820844
This study will evaluate the efficacy and safety of GSK1358820 in Japanese ...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-10-11
Trial ID
NCT02849418
Treatments Being Tested
This trial is a multicenter, double-blind, randomized, placebo-controlled s...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-04
Trial ID
NCT01153815
Treatments Being Tested
Primary objective is to evaluate the efficacy of single-dose treatment with...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-05
Trial ID
NCT01584843
Treatments Being Tested
This is a study to confirm the superior efficacy of GSK1358820 over placebo...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-05
Trial ID
NCT00460655
Treatments Being Tested